KC Lakshmaiah

A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer

George R. Blumenschein, Fairooz F. Kabbinavar, Hari Menon et al. · Annals of Oncology · 2011 · 90 citations

Phase Ii, Medicine, Pathology +6

Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: A timeline of clinical and microbial trends through the years

Govind Babu, D. Lokanatha, KC Lakshmaiah et al. · Indian Journal of Medical and Paediatric Oncology · 2016 · 53 citations · Full text

Excellent CBR and prolonged PFS in non-squamous NSCLC with oral CA-170, an inhibitor of VISTA and PD-L1

Venkatraman Radhakrishnan, Shripad Banavali, Sudeep Gupta et al. · Annals of Oncology · 2019 · 42 citations · Full text

Oncology, Novel Therapy, Clinical Therapeutic +8

Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B‐cell lymphoma

KC Lakshmaiah, Vikas Asati, Govind Babu K et al. · European Journal Of Haematology · 2018 · 33 citations

Colorectal cancer presenting as bone metastasis

M. Babu, Sunny Garg, KC Lakshmaiah et al. · Journal of Cancer Research and Therapeutics · 2017 · 32 citations · Full text